APA

Walter C. U., Mohareb F. A., Chaudhri N., Alsharif F., Zahrani H. A., Mohamed S., Rasheed W., Saleh A. J., Chebbo W., El Gohary G., Aljurf M. & Albitar M. (20130328). The t(9;11) confers good prognosis in AML patients treated with stem cell transplantation as compared to non-t(9;11) and other adverse-risk abnormalities. : Hematology/oncology and stem cell therapy.

Chicago

Walter Claudia Ulrike, Mohareb Fahad Al, Chaudhri Naeem, Alsharif Fahad, Zahrani Hazzaa Al, Mohamed Said, Rasheed Walid, Saleh Abu Jafar, Chebbo Wahiba, El Gohary Ghada, Aljurf Mahmoud and Albitar Maher. 20130328. The t(9;11) confers good prognosis in AML patients treated with stem cell transplantation as compared to non-t(9;11) and other adverse-risk abnormalities. : Hematology/oncology and stem cell therapy.

Harvard

Walter C. U., Mohareb F. A., Chaudhri N., Alsharif F., Zahrani H. A., Mohamed S., Rasheed W., Saleh A. J., Chebbo W., El Gohary G., Aljurf M. and Albitar M. (20130328). The t(9;11) confers good prognosis in AML patients treated with stem cell transplantation as compared to non-t(9;11) and other adverse-risk abnormalities. : Hematology/oncology and stem cell therapy.

MLA

Walter Claudia Ulrike, Mohareb Fahad Al, Chaudhri Naeem, Alsharif Fahad, Zahrani Hazzaa Al, Mohamed Said, Rasheed Walid, Saleh Abu Jafar, Chebbo Wahiba, El Gohary Ghada, Aljurf Mahmoud and Albitar Maher. The t(9;11) confers good prognosis in AML patients treated with stem cell transplantation as compared to non-t(9;11) and other adverse-risk abnormalities. : Hematology/oncology and stem cell therapy. 20130328.